Krka d d : Estimated Operating Results for the First Half of 2023
July 06, 2023 at 08:46 am EDT
Share
HomeMedia centerNewsEstimated Operating Results for the First Half of 2023
6. 7. 2023
Estimated Operating Results for the First Half of 2023
2 min. read
The 29th Annual General Meeting of Krka, d. d., Novo mesto is being held at the Otočec Šport Hotel today. The President of the Management Board and Chief Executive Jože Colarič has presented the key 2022 Krka Group business results and main operating estimates for the first half of this year. »We recorded growth across all sales regions and all groups of products and services. We are content with the estimated 7% sales growth, which has exceeded Krka's strategic target. Relative to the adjusted operating profit for the first half of 2022, the estimated operating profit for H1 2023 increased even more than sales despite inflation pressures, climbing 9%. This has resulted in the highest half-year EBIT in the history of Krka. Estimated half-year net profit was €170.1 million, 50% more than planned for the full-year 2023. This is, nevertheless, a decrease year-over-year because of high foreign exchange gains last year. The gap between the 2023 in 2022 net financial result is big over the half-year but is expected to close by the end of the year.«
The Supervisory Board is scheduled to discuss unaudited operating results of Krka and the Krka Group for the first half of 2023 at their regular meeting of 19 July, and a press release is due the next day.
Krka Group Financial Highlights
€ million
Estimate Jan-Jun 2023
Jan-Jun 2022
Index
Revenue
920.4
857.4
107
- Of that revenue from contracts with customers (products and services)
916.5
853.4
107
Earnings before interest, tax, depreciation and amortisation (EBITDA)*
288.6
192.4
150
Operating profit (EBIT)*
236.2
139.2
170
Net profit
170.1
236.2
72
Ratios
EBITDA margin
31.4 %
22.4 %
EBIT margin
25.7 %
16.2 %
Net profit margin (ROS)
18.5 %
27.5 %
* The adjusted EBITDA totalled €270.1 million for the first half-year 2022, and the adjusted EBIT €217.0 million. Half-year 2023 EBITDA was up 7% relative to the half-year adjusted 2022 EBITDA, and half-year 2023 EBIT climbed 9% relative to the half-year adjusted 2022 EBIT.
Sales
Estimated Product and Service Sales by Region
Region Slovenia,6.2
Region South-East Europe,13.9
Region East Europe,31.4
Region Central Europe,24.2
Region West Europe,20.1
Region Overseas Markets,4.2
RELATED CONTENT
Press release: Estimated Operating Results for the First Half of 2023 (6. 7. 2023)
KRKA dd published this content on 06 July 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 July 2023 12:45:09 UTC.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
KRKA, D. D. 
